Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Arginine deprivation/citrulline augmentation with ADI-PEG20 as novel therapy for complications in type 2 diabetes

Molecular Metabolism(2024)10.1016/j.molmet.2024.102020Source: DataRank Database

Arginine deprivation/citrulline augmentation with ADI-PEG20 as novel therapy for complications in type 2 diabetes is a research paper published in Molecular Metabolism (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.77)OA: goldTopics (68)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Porsche Sandow,Jing Wang ORCID,Zhimin Xu ORCID,Modesto Rojas ORCID,John S. Bomalaski ORCID

Live enrichment

PubMed:39214514 PMC:PMC11414555 OpenAlex:https://openalex.org/W4402023774

National Institutes of Health

Grant: R01-EY11766

National Institutes of Health

Grant: R01-EY03568

National Institutes of Health

Grant: P30 EY031631 /EY/NEI

NEI NIH HHS

Grant: P30 EY031631

NEI NIH HHS

Grant: R01 EY011766

National Institutes of Health

Grant: 5R01EY011766-04

CELLULAR MECHANISMS OF RETINAL ANGIOGENESIS

National Institutes of Health

Grant: 5P30EY031631-02

Center Core Grant for Vision Research

Pieris Pharmaceuticals

Augusta University

FWCI

2.77

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://doi.org/10.1016/j.molmet.2024.102020

GOLDhttps://doi.org/10.1016/j.molmet.2024.102020

publisherhttps://doi.org/10.1016/j.molmet.2024.102020

publisherhttps://api.elsevier.com/content/article/PII:S2212877824001510?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2212877824001510?httpAccept=text/plain

Fields of Study

Retinal Diseases and TreatmentsCancer Research and TreatmentsWound Healing and TreatmentsMedicine0301 basic medicine03 medical and health sciences0303 health sciencesAnimalsArginineMiceDiabetes Mellitus, Type 2Polyethylene GlycolsDiabetic RetinopathyCitrullineMaleHydrolasesMice, Inbred C57BLDiabetes Mellitus, ExperimentalBlood GlucoseOxidative StressBlood-Retinal Barrier

MeSH Terms

AnimalsArginineBlood GlucoseBlood-Retinal BarrierCitrullineDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetic RetinopathyHydrolasesMaleMice, Inbred C57BLPolyethylene GlycolsOxidative StressMice

Keywords

MedicineArginineCitrullineType 2 diabetesDiabetes mellitusInternal medicineBioinformaticsEndocrinologyChemistryBiologyBiochemistryAmino acidL-arginineAnti-inflammatoryDiabetic Complicationsvisual functionArginine DeiminaseL-citrullineArginase 1MaleBlood GlucoseHydrolasesPolyethylene GlycolsDiabetes Mellitus, ExperimentalMiceBlood-Retinal BarrierAnimalsDiabetic RetinopathyRC31-1245Mice, Inbred C57BLOxidative StressDiabetes Mellitus, Type 2Original Article

Sustainable Development Goals

SDG 0: Zero hunger